Nkarta, Inc. logo NKTX - Nkarta, Inc.

NEXT EARNINGS: Mar 25, 2026 (in 28 days) EPS Est: $-0.32
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 9
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $21.60 DETAILS
HIGH: $36.00
LOW: $15.00
MEDIAN: $16.00
CONSENSUS: $21.60
UPSIDE: 760.56%
Market Cap: 178.28M
Volume: 1,302,836
Avg Volume: 733,330
52 Week Range: 1.31-2.74
Sector: Healthcare
Industry: Biotechnology
Beta: 0.52
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 157
IPO Date: 2020-07-10
EPS (TTM): -1.60
P/E Ratio: -1.55
Revenue (TTM): N/A
Total Assets: 501.20M
Total Debt: 80.27M
Cash & Equiv: 27.87M
Rev Growth (5Y): -100.0%
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -26.6%
Debt/Equity: 0.20

Earnings History

Date EPS Actual EPS Est EPS Surprise Rev Actual Rev Est Rev Surprise
2025-11-10 $-0.29 $-0.32 +9.4%
2025-08-12 $-0.31 $-0.37 +16.2%
2025-05-14 $-0.43 $-0.44 +2.3%
2025-03-26 $-0.35 $-0.41 +14.6%
2024-11-07 $-0.39 $-0.37 -5.4%
2024-08-13 $-0.34 $-0.49 +30.6%
2024-05-09 $-0.58 $-0.56 -3.6%
2024-03-21 $-0.57 $-0.62 +8.1% $10.5M

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018
Revenue 0 0 0 0 0 115,385 6.55M
Net Income (108.79M) (117.50M) (113.84M) (86.08M) (91.36M) (21.08M) (274,503)
EPS -1.60 -2.40 -2.61 -2.62 -1.59 -2.55 -0.01
Total Assets 501.20M 378.88M 472.94M 273.90M 337.65M 48.41M 9.61M
Total Debt 80.27M 88.34M 82.93M 12.46M 8.92M 7.30M 12.71M
Cash & Equivalents 27.87M 31.04M 37.49M 60.82M 96.69M 20.61M 7.87M
Operating Cash Flow (99.70M) (86.16M) (57.00M) (67.93M) (43.51M) (18.37M) (5.18M)
Free Cash Flow (104.11M) (114.31M) (104.11M) (72.95M) (51.02M) (20.30M) (5.94M)
FCF per Share -1.53 -2.33 -2.39 -2.22 -1.60 -2.26 -0.12
Book Value 407.98M 273.29M 372.21M 250.97M 321.22M (25.48M) (5.40M)
Cash & ST Investments 267.35M 248.19M 352.14M 238.09M 314.91M 36.99M 7.87M
ROC Equity -0.27 -0.43 -0.31 -0.34 -0.28 N/A N/A